Please assess the completion status of the following clinical trial:

Trial Title: Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. MSM (cisgender male)~2. Self-reported use of non-alcohol substances of abuse in past 6 months~3. Currently taking PrEP~4. Has qualifying laboratory tests (Cr, hepatitis B immunization, STI testing and syphilis)~5. Age 18 or older~Exclusion Criteria:~1. Does not speak English~2. HIV positive~3. Identifies as transgender~4. Estimated creatinine clearance \<60ml/min~5. Active hepatitis B treatment~6. Does not own a smartphone~7. Taking proton pump inhibitors~8. History of Crohn's disease or ulcerative colitis~9. History of bowel surgery, gastric bypass, bowel stricture~10. History of GI malignancy or radiation to abdomen~11. Unable/unwilling to ingest digital pill

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Digital Pills (Type: EXPERIMENTAL): Digital Pills containing Truvada ingested once daily as PrEP

Based on this trial design, predict the completion outcome and termination type (if applicable).